Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
about
Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary diseaseRising Costs of COPD and the Potential for Maintenance Therapy to Slow the TrendLung volume reduction surgery for diffuse emphysemaThe use of extracorporeal carbon dioxide removal to avoid intubation in patients failing non-invasive ventilation--a cost analysis.Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims dataExpert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of ChinaSubtypes of patients experiencing exacerbations of COPD and associations with outcomes.Vulnerable COPD patients with comorbidities: the role of roflumilast.Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort studyConsider adding this drug to fight COPD that's severe.Standards of suitability for the management of chronic obstructive respiratory diseasesHyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary diseaseCOPD exacerbation frequency and its association with health care resource utilization and costs.Computed tomography manifestation of acute exacerbation of chronic obstructive pulmonary disease: A pilot studyDiet-induced obesity reprograms the inflammatory response of the murine lung to inhaled endotoxin.Development and feasibility of a self-management intervention for chronic obstructive pulmonary disease delivered with motivational interviewing strategies.Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPDDeterminants of between-hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit (AUDIPOC) in SpainRisk assessment of readmissions following an initial COPD-related hospitalization.Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four citiesClinical factors and comorbidities affecting the cost of hospital-treated COPD.Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD.Rehabilitation following hospitalization in patients with COPD: can it reduce readmissions?The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.Models for estimating projections for disease prevalence and burden: a systematic review focusing on chronic obstructive pulmonary disease.Controlled oxygen therapy at emergency department presentation increases the likelihood of achieving target oxygen saturations in patients with exacerbations of chronic obstructive pulmonary disease.Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis.Exacerbation of Chronic Obstructive Pulmonary Disease.Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease.Lower airway disease and pituitary surgery: Is there an association with postoperative cerebrospinal fluid leak?St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.One-year change in health status and subsequent outcomes in COPD.Hiatal Hernia on Chest High-Resolution Computed Tomography and Exacerbation Rates in COPD Individuals.Impact and prevention of severe exacerbations of COPD: a review of the evidence.Prehospital prognosis is difficult in patients with acute exacerbation of chronic obstructive pulmonary disease.Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study.Phenotyping COPD exacerbations using imaging and blood-based biomarkers.Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care.
P2860
Q24185964-551B6661-D077-4A2B-A543-34F8A80834FEQ27026708-EACFC08D-B7E0-4DDC-BF81-21E75A627143Q28279120-7F3F8E56-8997-45AD-8424-72CFBE18B074Q30315984-CF61A611-1C60-4660-B50D-72B3E80CBC38Q30822043-ED86FFDF-D083-4FEE-94F3-BEB4151FD800Q33559286-8437E01F-1441-40B7-94A8-485948D9B2ECQ33707570-0C29D941-0077-4D2E-8C87-CCBF42CE542AQ34566361-00C1280D-A071-483E-A2AE-D153EC13D450Q34767932-6224A308-C9A1-4ED1-BC0C-516CFE373378Q34789599-2ED2BC7C-E0D7-4A3B-BF61-2B4020FA1893Q34911219-F6DFEA22-0266-41C9-8382-ED51C18A8313Q36332198-F79A2D7A-4FFB-4338-87ED-B08F128A2BDEQ36352161-E01B1328-31C8-49AE-9C35-E06054D03EDEQ36524158-26E088C7-6651-4A3F-98B3-7E69FC3D153FQ36604858-F5DCD55D-9F64-475C-A96D-E1CBF1187571Q36650701-925B5D49-B712-4A35-96A3-A368ED99790BQ37094659-94912746-CDEB-450D-BDC0-537DE9C4B753Q37257520-D9DB5226-806B-4528-8309-AE6E2C0C9ECAQ37359282-463764CB-AB45-4854-920D-EBA4074B6635Q37365503-169FCEE3-D4F4-46D8-924A-64520E7D30CEQ37485333-5CB9A60A-96D7-4A5D-BC81-3DDB90F05F80Q38137141-0BA68803-E390-4DA4-ACBC-866C8EA0B6DCQ38296042-E623EEDF-9B45-47B3-84EA-62464F6412E2Q38321172-DE031419-4C2A-4079-AD2C-08DE29BC9ECDQ38348464-F2596D87-932A-45D3-BB9F-B49088C0013FQ38402341-0FE896F3-7E3E-4E76-AE4E-988AB38411C1Q38691237-BFB5C1C6-E80D-4409-A503-37A41F93A0AAQ38873365-B3C4AECB-D8DA-4C9A-9D3D-02CFD1326A11Q38879639-386C06E1-B921-4AF3-9F58-4FE2474E1485Q38946604-97783F59-D0B1-4C71-AFA3-B4154218CDF7Q39051219-5B197AA7-531B-414B-A119-92BB6AC72D18Q40076551-6C2FDB90-4080-412B-915D-BB631695FA4EQ40833745-BCBF101C-2C38-46E8-984D-D373A43F6654Q41420171-0DAF36E9-0495-46C2-8AB3-0858872B8BE8Q41434449-36D7A494-26AE-4F38-B69E-319599C177EFQ45803920-932DCA20-3F25-4D20-A801-D8577850EB8BQ47136948-F8EB3B9E-2912-4A62-A7BC-E36CB05962BCQ47147233-3016C247-7958-48AA-9E8E-A519A4EDEBF4Q47641932-309046C5-CA51-400C-9373-D0A601DF2FBDQ47710084-51CEAEB6-2009-45FF-81C8-D92F66D01AF8
P2860
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@en
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@nl
type
label
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@en
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@nl
prefLabel
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@en
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@nl
P2093
P2860
P1476
Acute exacerbations of COPD in ...... ictors of costs and mortality.
@en
P2093
Duane L Sherrill
Edward P Armstrong
Grant H Skrepnek
Prasadini N Perera
P2860
P304
P356
10.3109/15412555.2011.650239
P407
P577
2012-03-12T00:00:00Z